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Abstract 
Whether febrile seizures produce the neuropathology 
observed in human TLE patients remains controversial. In this 
study, we determine the pattern of BDNF mRNA expression in the 
rat hippocampus after single and recurrent hyperthermia- 
induced seizures, using the warm-water-immersion method. 
BDNF mRNA was detected in hippocampal sections by in situ 
hybridization with an 3 5s_raciio-labeled oligonucleotide probe 
complementary to the sequence of rat BDNF mRNA. Signal from 
the probe was visualized using plane-film autoradiography, and 
the intensity was quantified by computerized densitometry. In 
the hippocampi of both control and hyperthermic rats, BDNF 
mRNA was most highly localized to the dentate granular cell 
layer, CA3 pyramidal cell layer, CA1 pyramidal cell layer, the 
hilus, the molecular layer, CA3 stratum radiatum and CA1 
stratum oriens and radiatum, in descending order. The earliest 
increase in BDNF mRNA expression compared to controls was 
recorded in the granular cell layer after 3 seizures. By 9 seizures, 
an upregulation of BDNF mRNA was observed in all 8 measured 
regions of the hippocampus. The granular cell layer 
demonstrated the greatest maximum increase in BDNF mRNA 
(4.2-fold) compared to control levels. In contrast, the CA1 and 
CA3 pyramidal cell layers exhibited the smallest maximum 
increase (1.5-fold) of the regions measured in the hippocampus. 

In the dentate granular cell layer, a statistically significant 
increase in BDNF mRNA expression is observed between the 
following groups: 3 seizures vs. control; 6 seizures vs. control; 9 
seizures vs. control; and 9 seizures vs. 3 seizures. A statistically 
significant increase in BDNF expression was observed in CA1 
stratum oriens and the molecular layer of the dentate gyrus after 
9 seizures compared to controls. A strong positive correlation 
was found between the number of seizures experienced and the 
seizure duration. In addition, linear regression analysis revealed 
a strong correlation between the severity of the seizure and its 
duration. These findings suggest that BDNF mRNA upregulation 
during hyperthermic seizures protects hippocampal neurons 
from injury. The pattern of BDNF mRNA upregulation in the 
hippocampus suggests that cell populations which mount an 
insufficient BDNF response to seizures may be more vulnerable to 
injury and death during prolonged seizures. In addition to 
conferring neuroprotective properties, an increase in BDNF mRNA 
expression may enhance neuronal excitability and lengthen the 
seizure duration. 
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Introduction 
I. Temporal Lobe Epilepsy 
Epilepsy is a chronic neurologic disorder that is characterized 
by spontaneous, recurrent seizures. The term seizure comes from 
the Latin sacire, meaning "to take possession of." A seizure is 
defined as "a paroxysmal event due to abnormal, excessive, hyper- 
synchronous discharges from an aggregate of central nervous 
system neurons. The location and distribution of these abnormal 
discharges determines the outward manifestations of the seizures. 
The symptoms can range from involuntary motor activity, such as 
convulsions, to psychic or experiential symptoms not obvious to an 
outside observer. A person can experience a single episode of 
seizures during their lifetime due to an avoidable or correctable 
cause and not be diagnosed as having epilepsy. In order to have 
epilepsy, a person must have recurrent, unprovoked seizures that 
are due to a chronic, underlying cause (1). 
The incidence of epilepsy, worldwide, is approximately 0.3 to 
0.5%. The prevalence of epilepsy in the United states is 6 to 7 per 
1000, and 40 to 50 new cases develop annually per 100,000 (2). By 
comparison, 5 to 10% of the population will experience at least one 
seizure in their lifetime (1). In the general population, the risk of 
epilepsy increases from 1% at birth to 3% by 75 years of age (3). In 
two-thirds of the cases of epilepsy, the etiology is not identified. 
However, certain epileptic disorders manifest distinctive clinical and 
pathological characteristics which suggest a specific underlying 
etiology and are considered epilepsy syndromes (1). Thus, epilepsy 
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is not a single disorder but consists of a variety of diseases 
characterized by chronic, recurrent seizures. 
The different epilepsy syndromes are currently classified into 
separate categories based on clinical history, 
electroencephalographic findings, and etiology. The localization- 
related epilepsies and syndromes are characterized by partial 
seizures, in which seizure activity is limited to a discrete region of 
the brain. The generalized epilepsies and epilepsy syndromes are 
characterized by generalized seizures, in which seizure activity 
originates in both cerebral hemispheres (4). 
Partial seizures are the result of focal seizure activity in the 
brain, and this category is subdivided into simple and complex 
partial seizures. Complex partial seizures are characterized by focal 
seizure activity accompanied by an impairment of consciousness, 
whereby, the patient is unable to respond appropriately to 
environmental stimuli and has impaired recollection or awareness of 
the seizure episode. This type of seizure is usually preceded by 
auras--stereotyped, simple partial seizures which presage the onset 
of the ictal phase. The beginning of the ictal phase is often marked 
by a sudden behavioral arrest or motionless stare. From this point 
onward, the patient becomes amnestic of the seizure. Subsequently, 
automatisms ensue and can consist of a variety of motor 
disturbances such as lip smacking, chewing, swallowing, hand 
gestures ; however, they may be more elaborate behaviors. 
Typically, the patient is confused following the seizure and recovery 
may take seconds to hours (1,5). 
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Nearly one-third of complex partial seizures are not 
accompanied by EEG changes. Those that do demonstrate focal or 
lateralized sharp waves, spikes, and slow waves. These waves may 
follow several different patterns: rhythmic sinusoidal activity or 
repetitive spike discharges maximal over one region are most 
common (3). A lack of EEG is associated with brief seizures 
originating in deep regions such as orbitofrontal cortex or mesial 
temporal structures. 
Temporal lobe epilepsy (TLE) comprises almost two-thirds of 
all partial epilepsy syndromes (3). Mesial temporal lobe epilepsy 
(MTLE) is the most common epilepsy syndrome associated with 
complex partial seizures (1). These seizures arise from the 
hippocampus or amygdala. Psychic phenomena, visceral sensations, 
fear, anxiety and olfactory disturbances are commonly reported by 
TLE patients because their seizures arise in the temporal lobe. The 
complex partial seizures typically last from 30 to 120 seconds. 50% 
of patients also report secondarily generalized tonic-clonic seizures. 
Stress, sleep deprivation, and menstruation are some of the factors 
which may precipitate the onset of a seizure in this syndrome (3). 
The correct diagnosis of this syndrome is crucial because of its high 
incidence among the various epilepsy syndromes and because it 
tends to be refractory to medical treatment with anticonvulsants in 
30 to 40% of patients. However, the intractable seizures of TLE 
respond extremely well to surgical intervention (1). 
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II. Anatomy of the Hippocampus 
Before discussing the specific pathology found in TLE, a brief 
description of the hippocampus and its anatomy is necessary. The 
hippocampal formation lies in the floor of the temporal horn of the 
lateral ventricle. The individual fields of the hippocampus can be 
seen as adjacent strips of cortical tissue that run rostrocaudally in 
the temporal lobe and fold over each other in the shape of the letter 
"C" (5). The hippocampal formation includes the dentate gyrus 
(DG), the hippocampus proper also called Ammon's horn, the 
subicular complex-- divided into the subiculum, prosubiculum, and 
parasubiculum—and the entorhinal cortex. These anatomic regions 
are linked by prominent connections that unite them functionally 
(5). This discussion will focus primarily on defining Ammon's horn 
and the DG with reference to the other structures when necessary 
for an understanding of the pathology. A simplified description of 
neuronal projections will only include predominant ones that have 
been identified. 
Different nomenclatures have been used to describe the 
hippocampal formation. The system suggested by M. Rose divides 
the human hippocampal formation into five fields, H1-H5, based on 
cytoarchitectonic criteria and is often used (6). However, this 
system is not used widely for description in animal models. Instead, 
nomenclature proposed by Lorente de No has gained wider 
acceptance because it can be easily applied to descriptions of the 
human as well as animal brain (5). Based on studies of Nissl, fiber, 
and Golgi preparations, this system is notable for dividing the 
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hippocampus into four fields, CA1-CA4, and it is this terminology 
that will be referred to below. 
The DG consists of three layers. The principal layer consists of 
granule cells that send dendrites into the overlying molecular layer. 
Collectively, these two layers are often referred to as the fascia 
dentata (5). Dentate basket pyramidal cells also occupy the granule 
cell layer and give rise to GABAergic fibers that surround the 
granule cell bodies (7). The granule cells send axons, known as 
mossy fibers, to the proximal dendrites of the CA3 neurons and to 
the third layer of the DG—the hilus or polymorphic layer (8,9). The 
hilus contains several types of neurons. One class is the mossy cell 
that send fibers to the inner molecular layer (10). A second cell 
type is immunoreactive for peptide somatostatin and GABA. There 
is evidence to suggest that the cells of the hilus send projections 
exclusively to the DG (10). Cells of the DG do not project outside of 
the hippocampal formation (4). 
The hippocampus proper is divided into three fields, CA1-CA3. 
The area that Lorente de No termed CA4 is now included by many 
authors as the hilus. If the hippocampus is visualized in the shape 
of the letter "C," field CA3 borders the hilus of the DG where it 
terminates. CA2 follows the distal portion of CA3. The border 
between CA3 and CA2 is distinguished by a lack of mossy fiber input 
from the DG. CA1 lies adjacent to CA2 and is characterized by a 
more heterogeneous cell population than the other two 
hippocampal fields. It is estimated that 9.4% of its cells are 
interneurons and the rest are pyramidal cells (11). 
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All three fields share a similar laminar arrangement consisting 
of one cellular layer called the pyramidal cell layer. The border 
deep to the pyramidal layer, and formed by their axons, is termed 
the alveus. Between the alveus and the pyramidal cell layer is the 
stratum oriens—formed mostly by basal dendrites from the 
pyramidal cells and a population of tangentially oriented 
interneurons. Superficial to the pyramidal cell layer is the stratum 
lucidum, a layer exclusive to CA3 that is occupied by mossy fibers of 
the DG. CA3 is unique from CA1 and CA2 because it is the only 
hippocampal field to receive mossy fiber innervation from dentate 
granule cells. The next superficial layer, common to all three fields, 
is the stratum radiatum where the pyramidal cells of CA2 and CA3 
receive associational projections from other rostrocaudal levels of 
the hippocampus in addition to subcortical inputs. CA1 receives 
projections from CA2 and CA3 in stratum radiatum and stratum 
oriens through the Schaeffer collaterals. Next, CA1 pyramidal cells 
project predominantly to the subiculum (12). The most superficial 
layer, the stratum lacunosum-moleculare, contains perforant 
pathway projections from the entorhinal cortex which provide input 
to hippocampal pyramidal cells in CA1 and CA3. 
The subiculum lies adjacent to CA1 and their pyramidal cell 
layers overlap each other at their borders. Lorente de No applied 
the term prosubiculum to this overlapping region, and this term is 
used subsequently by some authors. However, contemporary 
authors consider most of the prosubiculum as part of the subiculum 
proper rather than as a distinct region since they are histologically 
similar (13). Although there is an overlapping region, the border 
6 

between CA1 and the subiculum is defined by a cell-free zone 
between the respective pyramidal cell layers (5). The subiculum is 
comprised of a pyramidal cell layer with apical dendrites extending 
superficially to form a wide molecular layer. The deepest portion of 
the pyramidal cell layer contains smaller neurons analogous to those 
in the polymorphic layer (14). Some entorhinal fibers of the 
perforant pathway also terminate in the subiculum (15). 
With the exception of the perforant pathway from the 
entorhinal cortex which reaches all hippocampal fields in parallel, 
information flow from the DG proceeds through the hippocampus in 
a serial and unidirectional fashion (5). After receiving input from 
the entorhinal cortex, the DG relays axons, the mossy fibers, to CA3 
and the hilus (8,9). In turn, CAS pyramidal cells provide input to 
subcortical regions and to CA1 (9). Finally, CA1 projects to the 
subiculum (12). 
III. Neuropathology of TLE 
Temporal lobe epilepsy is strongly associated with a specific 
neuropathology known as hippocampal sclerosis. First described in 
1825, sclerosis refers to the gross appearance of a hard, shrunken 
hippocampus frequently found in autopsy studies of patients with a 
history of chronic epilepsy (16). The first microscopic study of this 
pathology was done by Sommer in 1880, using tissue from an 
epilepsy patient who manifested clinical symptoms similar to those 
we now attribute to TLE. In his report, he described a specific 
pattern of neuron loss in the hippocampus. Particularly, he noted 
extensive loss of pyramidal neurons in what is now considered CA1 
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and prosubiculum (17). This region is now referred to as Sommer's 
sector because the pattern of loss in this region is a consistent 
finding in TLE. He also observed loss of the granule cells and hilar 
neurons in the DG (17). 
These results were corroborated by Bratz in 1899. In addition 
to neuron loss in Sommer's sector and the hilus, he documents an 
area of pyramidal cells in CA2 and CA3 that were resistant to injury . 
He also found complete preservation of subicular neurons, 
separated by a sharp boundary from the extensive prosubicular 
damage. His study drew from 50 autopsy cases of chronic seizures 
stemming from different causes, including syphilis and cysticercosis. 
From his investigation, he observed hippocampal sclerosis in 50% of 
the cases and concluded that not all epilepsy is caused by 
hippocampal pathology (18). 
Many early studies report an association between seizures and 
hippocampal sclerosis (19). Stauder was one of the first to 
demonstrate an association between hippocampal sclerosis and 
temporal lobe seizures, specifically (20). Reviewing autopsy 
material from patients with chronic seizures, he observed that 92% 
of autopsy cases with hippocampal sclerosis had signs of complex 
partial temporal lobe seizures. In contrast, 88% of those epileptics 
without hippocampal pathology were negative for temporal lobe 
signs. A similar conclusion can be drawn from the work of 
Margerison and Corsellis who used EEG criteria to identify patients 
with temporal lobe seizures. Hippocampal sclerosis was present in 
58% of cases exhibiting TLE. 
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Surgical evidence not only links TLE and hippocampal 
sclerosis, but also suggests that hippocampal sclerosis may produce 
or contribute to the chronic seizures that characterize TLE. For 
example, better seizure control is obtained for intractable TLE 
patients when surgical treatment includes resection of the 
hippocampus. A recent study reports a 69% seizure control rate for 
TLE with total hippocampectomy versus only 38% with partial 
removal (21). In a separate study, hippocampal sclerosis was the 
only pathological substrate found in 83% of patients that achieved 
seizure control after surgical resection (22). Collectively, these 
findings suggest that hippocampal sclerosis has a functional role in 
seizure formation. 
Modern research has confirmed and elaborated on the initial 
description of hippocampal pathology given by Bratz and Sommer. 
Using densitometric techniques, Mathern et al. were able to quantify 
the proportion of neuron loss in hippocampal sclerosis compared to 
controls: they report a 50% decrease in granule cells; 55% 
decrease in the hilus and the portion of CA3 terminating in the hilus; 
76% decrease in CA1 and prosubiculum, comprising Sommer's 
sector; and 41% decrease in CA3 and CA2, considered the resistant 
region by Bratz (5). Mouritzen Dam performed cell counts of 
hippocampi obtained from TLE patients and found neuron loss in all 
hippocampal fields and the DG (23,24). Also, there is evidence for 
interneuron loss in the hilus that is limited to three cell types: 
somatostatin, neuropeptide Y, and substance P neurons (25,26). 
Further findings report hippocampal sclerosis tends to be 
unilateral in chronic TLE; however, there is bilateral hippocampal 
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neuron loss. Meenke and Veith found unilateral hippocampal 
sclerosis in 30.5% of their patient population, but bilateral damage 
was reported in 56% (27). In a more limited study, the 
hippocampus contralateral to the side of sclerosis had an average of 
30% neuron loss; however, the damage to this side was diffuse and 
greatest in CA2 instead of Sommer's sector (28). 
Research indicates that TLE pathology is not limited to the 
hippocampus, but may extend to other regions of the brain. In 
addition to neuron loss in Ammon's horn, concomitant damage has 
been found in the amygdala and temporal neocortex of some 
patients with TLE. Falconer et al. coined the term mesial temporal 
sclerosis (MTS) to describe the pattern of hippocampal sclerosis 
coupled with additional injury outside of the hippocampus (29). 
According to one study, damage to the amygdala was seen in 64% of 
patients with a finding of hippocampal sclerosis (30). Studies of 
surgical specimens estimated that neuron loss in the amygdala was 
60% of controls (31). Recent MRI studies suggest involvement of 
both the amygdala and hippocampus in MTS (32). In fact, reviews 
of the literature revealed that MTS is the predominant pathology in 
temporal lobe resections for intractable TLE (39). Frequency of MTS 
is reported from 49% to as high as 76% (29,40). 
In addition to neuronal injury and loss, there is growth of new 
fibers in a proportion of TLE cases—a phenomenon called sprouting 
(33). The best documented sprouting is in granule cell mossy fibers 
which send novel, recurrent collaterals into the inner molecular 
layer of the DG. This phenomenon occurs predominantly in mesial 
temporal lobe epilepsy (MTLE)—TLE not stemming from an 

epileptogenic mass lesion (25). A small amount of mossy fiber 
sprouting into the inner molecular layer is detected in TLE patients 
with temporal mass lesions (MaTLE); however, densitometry reveals 
that sprouting is significantly greater in MTLE. (34). In addition to 
mossy fibers, three other types of axons have demonstrated 
sprouting in MTLE. NPY axons are increased in density in the 
molecular layer of the DG (35). Likewise, somatostatin fibers are 
increased throughout the molecular layer of the DG, preferentially 
synapsing with apical dendrites of granule cells (25). Sprouting is 
also observed in fibers immunoreactive for substance P in the 
granule cell layer of the DG (36). 
IV. Etiology of TLE--A Possible Role for Febrile Convulsions 
A number of different etiologies have been proposed as causes 
of TLE. These factors are derived mostly from histologic 
examination of lesions found in patients who underwent surgical 
resection as treatment for intractable TLE (37). One group of 
lesions is attributed to abnormalities during development and 
includes findings such as arachnoid cysts, epidermoid cysts and 
heterotopic grey matter (37). More recently, neuronal migration 
disorders (NMD) were the most common neuropathological finding 
in a study of children with medically refractory epilepsy treated 
surgically (62). Another possible factor is head trauma, suggested 
by a finding of focal scars and gliosis in the temporal cortex or 
white matter and supported by a clinical history (29). Vascular 
malformations and various neoplasms, such as astrocytoma or 
oligodendrogliomas, have been removed from the temporal lobe 

with subsequent control of seizures (38). Inflammatory damage has 
also been suggested as an etiology based on microscopic evidence of 
prior necrotizing encephalitis or meningitis. Nonetheless, MTS 
remains the most frequently reported lesion in TLE patients (39). 
In looking for possible etiologic factors of epilepsy, Falconer 
observed that in the subgroup of TLE patients with a finding of MTS, 
60% had a previous history of febrile convulsions (FC) as children 
(29). Subsequent studies of temporal lobectomy for intractable TLE 
confirm this finding. In the population of TLE patients with MTS, the 
percentage with a prior history of FCs is reported between 18-79%, 
depending on the study (40,41). 
Febrile convulsions or seizures are defined as "an event in 
infancy or childhood, usually occurring between 3 months and 5 
years of age, which is associated with fever but without evidence of 
intracranial infection or defined cause. Seizures with fever in 
children who have suffered a previous non-febrile seizure are 
excluded" (42,43). The diagnosis is clinical, and EEG may serve to 
confirm seizure activity. Although there is not a consensus on the 
body temperature required to produce an FC, many agree that a 
temperature of at least 38.5 is required (44). A study by Aicardi 
found that three-quarters of children with FCs have temperatures of 
39 0c or higher, and one-quarter have temperatures greater than 40 
0c (45). Some hypothesize that it is the rate of rise in body 
temperature that determines if FCs will occur, but there is no 
clinical data to support this (46,47). 
FCs are the most common form of childhood seizures (48). It 
is estimated to affect 3 percent of all children, but this rate is higher 

in certain populations, reportedly reaching 15% in Guam (49). One- 
third of children will have a recurrent febrile seizure after their first 
episode (50). Some studies find that children with FCs are at 
increased risk for subsequent, unprovoked afebrile seizures, 
including epilepsy (48). The risk for developing epilepsy after FCs 
varies by study. Millichap, in a review of the literature, found the 
rate was 20%—the lowest incidence was 2.6% and the highest was 
100% (52). In particular, children with FCs exhibiting complex 
features--prolonged, focal or recurrent seizures--appear to be at 
significantly higher risk for subsequent, unprovoked partial 
seizures. The risk is cumulative with the addition of each complex 
feature; children with FCs with all three complex features have a 49 
% risk of later seizures (51). More recent prospective studies 
estimate the incidence of epilepsy from 1.3% to 12% (50,53). 
However, only children with complicated or prolonged FCs have a 
higher risk for epilepsy (51,54). 
The precise nature of the relationship between FCs and the 
development of MTS and TLE remains controversial (39). Evidence 
to support the hypothesis that FCs cause neuronal injury—HS and 
MTS—that results in TLE comes from retrospective studies of 
patients who underwent surgical resection for treatment of 
intractable TLE. As previously mentioned, a significant proportion 
of patients with TLE and MTS have had prior histories of FCs. 
Additional support for this hypothesis can be found in a study, by 
Sagar and Oxbury, that documents a significant correlation between 
prolonged, early childhood convulsions and the severity of 
hippocampal neuron loss in TLE (55). This re-emphasizes the 

prolonged nature of FCs as necessary for producing neuron loss and 
contributing to an increased risk of recurrent seizures. 
More recent data corroborates these findings. Mathern et al. 
reviewed TLE surgical resection cases and examined the clinical 
histories for events that involved loss of consciousness greater than 
30 minutes or alterations of cognition for more than 4 hours, 
termed initial precipitating injuries (IPI). 41% of IPIs involved either 
prolonged seizures or status epilepticus. Patients with IPIs showed 
more severe neuron loss in the pattern of hippocampal sclerosis 
than non-IPI patients or age-comparable autopsy specimens (56). 
Furthermore, patients with IPIs and hippocampal sclerosis had the 
best seizure control following surgical resection (57). MRI studies 
have also shown a correlation between prolonged FCs in childhood 
and more severe forms of MTS (58). Despite these results, 
prospective and population-based studies of children with FCs have 
failed to find an association with temporal lobe epilepsy (51,59) 
This failure led others to propose that FCs do not cause MTS or 
TLE, but are merely an age-specific marker for TLE (59). According 
to this hypothesis, FCs, MTS and TLE are all products of an 
underlying pathology (39). In one study, MRI was used to examine 
the brains of members from two families with a marked history of 
FCs. A similar hippocampal malformation was found in all subjects 
with FCs or TLE as well as a few unaffected relatives (60). This 
finding suggests that pre-existing pathology, such as an hippocampal 
malformation, may predispose children to the development of FCs. 
In turn, FCs cause MTS that eventually leads to TLE. Another 
conclusion that can be drawn is that FCs and MTS are independent 

phenomena, and they are both caused by the same pre-existing 
pathology. Animal experiments support this latter scenario. For 
example, when neuronal migration disorders (NMD) were induced in 
the brain, NMD rats had lower thresholds for seizures and 
hippocampal damage than normal controls after exposure to 
hyperthermia (61). In these NMD rats, hippocampal damage 
developed independently of seizure activity. 
Despite the amount of research published on the subject, the 
precise relationship between FCs, MTS and the development of TLE 
remains to be defined. 
V. The Hyperthermia Model of Febrile Seizures 
In an attempt to resolve the conflicting reports in human 
studies regarding the role of FCs in TLE, some researchers have 
turned to animal models in order to gain insight into febrile 
seizures. One such model, developed by Baram and associates, uses 
a stream of warm air (42-43 ^C) to elevate the core body 
temperature of immature rats in order to simulate the febrile state 
in humans and elicit seizures. The advantages of using an animal 
model are that pre-existing lesions can be excluded, and the 
investigator can control both the duration and magnitude of 
hyperthermia. Thus, hyperthermic seizures can be closely 
regulated. Stereotyped, reproducible seizures are elicited in 98% of 
the rats in this model (63). Applying patch clamp techniques to 
examine this model, Baram was able to show that febrile seizures 
cause a selective presynaptic increase in inhibitory synaptic 
transmission that persists into adulthood. In vivo, the 

hyperthermic-seizure rats demonstrated enhanced susceptibility to 
limbic seizures: a subthreshold dose of intraperitoneally- 
administered kainate produced status epilepticus but only resulted 
in behavioral hyperactivity in their normothermic controls (64). 
This finding was substantiated by in vitro data, gathered from 
experimental rats, that describes self-sustaining excitability 
recorded in hippocampal-entorhinal cortical brain slices after 
electrical stimulation. However, subsequent spontaneous seizures 
were not produced. Normothermic rats and rats exposed to 
hyperthermia without seizures did not display any changes in 
hippocampal excitability (64). Baram also reports transient 
alterations in neuronal structure, but not neuron loss, in the 
amygdala and pyramidal cell layer of fields CA1 and CA3 brought 
about by hyperthermic seizures in the rat (65). These elegant 
experiments demonstrate that febrile seizures can produce long¬ 
term changes in hippocampal excitability and susceptibility to 
subsequent seizures. 
In order to examine the issue of whether febrile seizures can 
produce the hippocampal neuropathology seen in TLE patients, Jiang 
et al. employed another variation of the hyperthermia model in 
immature rats (66). Instead of warm air, a temperature-controlled 
water bath was used to increase the core temperature of the rats. 
The principal advantage of this warm-water-immersion model, first 
developed by Klauenberg and Sparber, is a more effective rate of 
heat transfer, simulating the rapid core temperature elevation in 
human febrile seizures (48,67). Some authors have speculated that 
it is the rate of rise rather than an absolute temperature which 

triggers a FC (46,47). This model allows for repeated induction of 
seizures. Some rats with a history of multiple, short-duration FCs 
develop prolonged seizures upon subsequent exposure 
hyperthermia. These prolonged seizures are similar to status 
epilepticus in humans. 
The warm-water-immersion model bears several striking 
similarities to human FCs and TLE. Holtzman reports that the 
increase in seizure threshold coupled with changes in EEG patterns 
in maturing rat pups, as they are warmed, resembles the seizure 
characteristics associated with FCs in young children (68). 
Additionally, the neuropathology in rats that experienced prolonged 
seizures displays marked resemblance to pathology observed in 
tissue resected from human TLE patients: 1) neurodegeneration was 
confined to the hippocampus, temporal lobe (amygdala, pyriform 
cortex, entorhinal cortex), and dorsomedial nucleus of the 
thalamus, 2) minimal degeneration was detected in neocortex, 3) 
degeneration was seen in the hilus, CA3, and CA1, and 4) the dentate 
granule cell layer and CA2 were more resistant to injury (66). In 
contrast, rats that only underwent short-duration seizures did not 
manifest any detectable signs of neurodegeneration. This finding, in 
an animal model, corroborates the strong association, initially 
described by Sagar and Oxbury, between prolonged FCs and the 
severity of hippocampal neuron loss in human TLE (55). Sprouting 
of recurrent collaterals from the mossy fibers into the inner 
molecular layer of the DG was also seen in rats that experienced 
short-duration, hyperthermic seizures. Furthermore, the degree of 

sprouting correlated with the number of short-duration seizures 
that were induced (66). 
Pathology in this model does have some differences from 
human TLE. One notable departure from human studies is that 
collateral sprouting was not correlated with the degree of granule 
cell loss in the rat (66). Another difference is that the pattern of 
hippocampal neuron loss was similar, bilaterally; whereas, in human 
studies, there is an asymmetric pattern of hippocampal neuron loss 
(27, 66). Additionally, it is not known whether spontaneous 
seizures arise in this model, subsequent to the status epilepticus 
seizures. However, spontaneous seizures have been documented in 
all other rat models following treatments that produced status 
epilepticus—pilocarpine model, kainic acid model, and continuous- 
stimulation model (69-71). Efforts are currently underway to 
monitor for this phenomenon. 
Although there are differences between the hyperthermia 
model in rats and human FCs and TLE, the similarities in seizure 
semiology and neuropathology make it an invaluable model for 
future study. 
VI. The Role of Brain-derived Neurotrophic Factor in TLE 
One promising area of investigation examines the potential 
role of brain-derived neurotrophic factor (BDNF) in epileptogenesis 
and synaptic modulation. BDNF is a member of the neurotrophin 
family of trophic molecules which includes nerve growth factor 
(NGF), neurotrophin-3 (NT-3) and neurotrophin-4/5 (NT-4/5). 
BDNF mediates its effects through high-affinity interactions with the 

tyrosine kinase receptor, TrkB. Neurons expressing the BDNF gene 
also contain mRNA for TrkB, indicating that BDNF may function 
locally via autocrine and paracrine mechanisms (74). During 
normal development of the PNS and CNS, BDNF promotes survival of 
cranial and spinal sensory neurons; however, its function in the 
mature CNS is poorly understood (75,76). BDNF is widely 
distributed throughout the CNS, but the highest level of BDNF mRNA 
expression is in the dentate gyrus (DG), CAS and CA2 pyramidal 
neurons of the hippocampus (77). 
The discovery that seizures can induce an increase in BDNF 
mRNA expression in cortical and hippocampal neurons led scientists 
to speculate that its upregulation could be responsible for the 
sprouting and synaptic reorganization seen in human epilepsy (78). 
Indirect evidence to support this hypothesis comes from in vitro 
experiments in which exogenous BDNF was shown to protect 
hippocampal neurons and enhance cell survival against various 
insults such as hypoglycemia and excitotoxic damage from 
glutamate (79). In these experiments, excitotoxic injury is mediated 
by a large influx of Ca2+ into the cell. BDNF protects these cells by 
stabilizing the intracellular [Ca^+] homeostasis; one way it might do 
this is by stimulating expression of calcium-binding protein 
calbindin (80,81). There is evidence to suggest that BDNF may 
directly induce mossy fiber sprouting: in vitro, exogenously 
administered BDNF has been shown to increase axonal branching of 
dentate granule cells of the hippocampus (82). From this body of 
research, it is plausible that BDNF, when induced by brain insults 
such as FCs, can promote the survival of a certain subpopulation of 

hyperexcitable neurons in the hippocampus leading to the formation 
of an epileptic focus. A second possibility is that an increase in 
BDNF from basal levels promotes the formation of aberrant synaptic 
connections through axonal sprouting which results in the 
formation of abnormal, hyperexcitable circuits. Hypothetically, 
epileptogenic remodeling following FCs could involve a combination 
of these processes. 
An alternative conclusion is that an increase in BDNF confers 
resistance to neuronal injury in the hippocampus during simple or 
short-duration FCs. However, if there is an insufficient BDNF 
response during prolonged seizure activity such as status epilepticus 
or complicated FCs, this could result in neuron loss and TLE. This 
could explain why neurodegeneration is only observed in 
hyperthermic rats following status epilepticus and not after short- 
duration seizures alone (66). 
Recent research demonstrates that BDNF contributes to 
epileptogenesis by directly enhancing excitatory synaptic 
transmission both in vitro and in vivo. BDNF enhanced excitability 
at mossy fiber synapses when administered to brain slices taken 
from pilocarpine-treated rats with spontaneous seizures (83). In 
mutant mice with genetically reduced levels of BDNF expression, 
seizure induction by kindling was suppressed (84). Conversely, 
transgenic mice which overexpress BDNF have spontaneous seizures 
and are more sensitive to seizure induction by kainic acid (85). 
When TrkB receptors known to mediate the actions of BDNF were 
blocked in vivo, seizure-induction was inhibited in the kindling rat 
model of epilepsy (86). The significance of these findings for 
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human TLE is made more compelling by the report that patients with 
TLE show an increase in BDNF expression, particularly in the DG, 
compared to normal human subjects (87,88). 
enhances fast excitatory synaptic transmission 
exogenously administered to brain slices taken 
patients (89). 
Furthermore, BDNF 
in the DG when 
from human TEE 

Statement of Purpose 
The purpose of this experiment is to determine the pattern 
and quantity of BDNF mRNA expression in the hippocampus of the 
rat after single and repeated hyperthermia-induced seizures. These 
findings will be compared to the pattern of BDNF mRNA expression 
observed in rats with status epilepticus and non-seizure controls. 
Hypothesis 
Given the known neuroprotective properties of BDNF, we 
hypothesize that BDNF mRNA expression is increased in the 
hippocampus of rats experiencing short-duration, hyperthermic 
seizures without detectable signs of neuronal injury. In contrast, we 
predict that an insufficient BDNF mRNA response accounts for the 
pattern of excitotoxic injury and cell death observed in rats with 
prolonged seizure duration--such as status epilepticus--and 
neuronal loss. 
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Methods 
Experimental Design 
This experiment was designed to investigate the levels of BDNF 
expression in the hippocampus of the rat brain as a function of the 
number of seizures induced by hyperthermia. For this purpose, a 
model of febrile seizures in the immature rat was used in which 
seizures could be elicited reliably and repeatedly via exposure of the 
animal to hyperthermia in a heated water bath. The animals were 
sacrificed when the correct number of seizures was obtained and 
their brains were immediately harvested for study. BDNF expression 
was detected in thin coronal sections of the hippocampus via in situ 
hybridization with an 35s_iabepeci 50 mer oligonucleotide probe 
designed for specific binding to rat BDNF mRNA. The signal from 
the probe was detected and visualized by autoradiography onto 
plain film. This technique also allowed for determining the 
localization of the probe to different regions of the hippocampus. 
BDNF mRNA expression was measured as the strength of the signal 
from the probe. This signal was quantified by densitometric analysis 
of the autoradiogram coexposed with standards. 
This study was comprised of four experimental groups only 
differing in the number of seizures induced by hyperthermia (1, 3, 6 
and 9 seizure groups, respectively) plus one control group. Each of 
the four experimental groups consisted of 3 young Sprague-Dawley 
rats. For each of the four experimental groups there was a 
separate, age and sex-matched rat serving as a control, which 
underwent the exact laboratory conditions and induction trials as 
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the respective experimental group, with the exception of 
hyperthermia and seizure activity. Subsequently, these four control 
rats were assembled as one control group. The rationale for this 
was that the amount of BDNF mRNA detected by in situ hybridization 
was similar among these normothermic control rats. 
Originally, this study was designed with a larger sample size 
(n=6), but this number was reduced (n=3) because some subjects 
died before the correct number of seizures could be induced. Due 
to the long period of time required to prepare this rat model and 
perform in situ hybridization, more subjects could not be generated 
to meet the deadline for this study. 
Subjects 
The subjects selected for this experiment were male Sprague-Dawley 
rats obtained at age 15 days. They were housed with their mothers 
under standard laboratory conditions until they were weaned at ~2 1 
days. By age 22 days, the rats had a mean weight of ~100 g. They 
were then moved and housed in groups of four with ad libitum 
access to food and water. A daylight cycle of 12:12 h was 
maintained. Both control and experimental groups started with 22- 
day-old rats which grew older as they continued to be stimulated to 
the correct number of seizures. Although an age comparison 
between the rat and human brain remains an approximation, it has 
been suggested that the 5 to 7-day-old rat brain is equivalent to 
that of a full-term newborn infant. The 15-day-old rat brain 
corresponds to a human brain that is a few months to 1-year-old, 
and the 28-day-old rat brain is approximate to the brain of a 2-year- 

old child. The febrile seizures associated with the development of 
TLE in humans occur in the period between 6 months to 5 years of 
age. Hence, the 22-day-old rat most closely models this period of 
development in the human brain. 
Seizure Induction 
All protocols involving animal use were approved by the Yale 
Animal Care and Use committee. Seizure induction trials were 
begun on postnatal day 22 by exposing the subjects to 
hyperthermia. In brief, the subject's core body temperature was 
raised by immersion in a temperature-controlled water bath 
maintained at 45^ C for five minutes or less if seizure activity was 
elicited. A water temperature of 45^ C does not produce skin 
damage at exposures <1 hr. In human subjects, this temperature 
produces only a mild "pricking pain" which resolves in a few 
seconds. These trials were conducted using a glass chromatography 
tank (30 x 30 x 60 cm) containing water to a depth that the animal 
could stand upright supported by the side of the tank with only its 
head and forelimbs above water level. At the first sign of seizure 
onset, the animal was immediately removed from the water and 
placed in an observation chamber. Seizure latency was measured as 
the interval between when the rat was placed in the water until its 
first sign of seizure activity. The seizure duration was measured as 
the time from seizure onset to when the rat first righted itself and 
appeared conscious. The state of consciousness was determined by 
the responsiveness of the rat to one of the following stimuli: 
tapping on the cage, responsiveness to touch or movement of an 
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object before its eyes. At the end of this period of observation, the 
rat was gently dried with a towel and returned to its home cage. This 
procedure was repeated with an interval of two days between trials 
until the correct number of seizures was obtained. 
Seizure severity was rated based on the appearance of the 
following seizure characteristics: 0 for no seizure; 1 for facial 
clonus; 2 for head nodding; 3 for forelimb clonus; 4 for rearing 
(standing posture aided by tail and laterally spread hind limbs 
showing increased tone); and 5 for rearing and falling. 
Sex-matched control rats underwent the same conditions of 
induction as outlined above for their experimental counterparts 
with the exception that they were placed in water maintained at 
37^C for four minutes and did not exhibit seizure activity. Likewise, 
these trials were begun on postnatal day 22. Control subjects 
underwent the same number of trials as their respective 
experimental group. 
Tissue Collection 
One hour after seizure induction, the rats were anesthetized 
by inhalation of CO2 gas for thirty seconds and sacrificed by 
decapitation. The brains were harvested within three minutes of 
death and embedded in OCT before being transferred onto dry ice to 
solidify. The coronal block was stored at -70^ C. 
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Cryostat Sectioning 
16 um coronal sections were made with a cryostat at -14-0 C. 
Sections were collected with pre-warmed, amino-alkylated glass 
slides and stored in cryoboxes at -70^ C. 
Synthesis of BDNF Oligoprobe 
To detect rat BDNF mRNA, a 50 mer oligonucleotide 
complementary to rat BDNF corresponding to nucleotides 746-795 
of pig BDNF was used (Leibrock et al., 1989). The sequence of the 
rat BDNF probe is as follows: 5'-AGTTCCAGTGCCTTTTGTCTATGC- 
CCCTGCAGCCTTCCTTCGTGTAACCC-3'. This sequence has a GC 
content of 56%. Hybrids with a higher frequency of G-C pairs are 
more stable than those with a predominant A-C pair content 
although a GC content of >65% causes non-specific binding since the 
thermal stability of the probes is greater (Current techniques). 
Synthesis was performed by the Yale Oligonucleotide Laboratory 
with a DNA synthesizer. 
Terminal Transferase Labeling Reaction 
Oligoprobes for BDNF were labeled with 35S at the 3' end using 
a kit by Boehringer-Mannheim according to the manufacturer's 
protocol. The probe was purified by applying lOOuL of reaction 
solution to a Sephadex G-25 spin column that was centrifuged for 
four minutes at 2,700 rpm. The eluate was collected and activity 
was determined by liquid scintillation counting (-100,000 cpm). 
2uL of 1M DTT was added to the eluate. The probe was stored at - 
200 c. 
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Fixing Sections 
In order to maintain morphological integrity of the tissue, 
retain target nucleic acid intact and allow good accessibility to 
probes, a paraformaldehyde fixative was chosen for its known cross- 
linking properties in the following protocol. Slides were transferred 
directly from a -70^ C freezer to staining racks and placed in the 
fixative. Fixation consisted of five minutes in ice cold 4% 
depolymerized paraformaldehyde (PFA) solution; five minutes in IX 
PBS; five minutes in 70% ethanol; and five minutes in 95% ethanol. 
The slides were allowed to air dry in the staining racks for thirty 
minutes while covered with Kimwipes to prevent contamination by 
any particulate matter that may be in the air. All steps were 
performed at room temperature (RT) except where indicated; all 
solutions were made with DEPC-water; glassware was rendered 
RNase-free prior to use. 
In Situ Hybridization 
Hybridization buffer was prepared fresh assuming lOOul/slide 
(4X SSC, 20% dextran sulfate, 0.25mg/ml yeast tRNA, 0.25mg/ml 
poly A, 0.25 mg/ml Salmon testes DNA, 2.5X Denhart's solution, and 
70% deionized formamide). The buffer was mixed by vortexing and 
centrifuged to remove bubbles before being warmed to 42^ C in a 
water bath. 2uL of oligonucleotide probe (-100,000 cpm) was 
added per lOOul of hybridization buffer, and the mixture was 
vortexed. The fixed slides were placed in a hybridization chamber, 
and lOOul of hybridization buffer was applied to each slide. To 
28 

limit evaporation of this buffer and enhance its distribution over the 
tissue samples, Parafilm strips were placed over the slides instead of 
glass coverslips. Air bubbles are more easily eliminated using 
Parafilm and this promotes even distribution of hybridization buffer 
over the tissue sample. Humidity inside the chamber was 
maintained by adding a small amount of solution composed of 4X 
SSC and 50% formamide to the floor of the chamber before sealing 
the lid and seams with tape. Incubation proceeded overnight at a 
temperature of 42^ C. Oligoprobes hybridize optimally at 5^ C 
below Tm~ the temperature of dissociation and reassociation of 
50% of the hybrids. Here, it was calculated as Tm=20 C (A+T bp) + 
40 C (G+C bp) - 5° C. 
Post-hybridization Wash and Autoradiography 
Coverslips were gently removed and the slides were washed in 
2x SSC followed by a one minute wash in IX SSC, both at RT. The 
slides were soaked in IX SSC with lOmM DTT at 60^ C for thirty 
minutes before being rinsed briefly in IX SSC, 0.1X SSC, 70% 
ethanol, and 95% ethanol. The slides were air-dried for thirty 
minutes and coexposed to Biomax film with a slide of standards 
for four weeks at RT. 
Analysis of Autoradiograms by Densitometry 
The density of grains on the autoradiograms was measured 
using a microcomputer imaging device (Imaging Software). From 
this density measurement, the amount of radioactivity could be 
extrapolated by MCID/M4 software (Imaging Software) from a range 
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of standard values generated by measuring the densities of 
standards of known activity coexposed with the hybridized slides at 
the time of autoradiography. From each rat, autoradiograms of 
three brain sections were selected for analysis--one representative 
of the caudal hippocampus, one representative of the middle 
hippocampus and one representative of the rostral hippocampus. 
The density of the following regions was measured--in CA1, stratum 
oriens, the pyramidal cell layer, and stratum radiatum; in CA3, the 
pyramidal cell layer and stratum radiatum; in the dentate gyrus, the 
granule cell layer, the molecular cell layer and the hilus (Figure 1). 
Measurements were obtained for each section, bilaterally. This 
yielded 16 measurements per brain section. 
Statistical Analysis of Data 
For each of the eight regions of the hippocampus and dentate 
gyrus analyzed by densitometry, a mean value was calculated from 
the rostral, middle, and caudal measurements. Hence, each animal 
had a calculated mean value for each of the eight hippocampal 
regions (Appendix I). 
Because of the small sample size, a Kruskal-Wallis one-way 
analysis of variance was performed, on the mean values, to detect 
overall variance between groups for the eight hippocampal regions 
examined. Differences in BDNF mRNA levels, between seizure 
groups and between a seizure group and the control group, were 
compared using the Mann-Whitney one-tailed U-test. 
Statistical linear regression was performed to determine the 
strength of correlation between seizure grade and seizure duration. 
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Linear regression was also performed to determine the strength of 
correlation between the seizure number and seizure duration. 
Note: All of the above procedures were performed by the author 
except where noted in the text. 

Results 
Description of Seizures 
The rats initially swam upon being placed in the water. Within 
a few seconds, they stood up on the floor of the tank supported by 
their hind limbs. The forelimbs were used for support in this 
position against the sides of the tank. Some moved along the sides 
of the tank in this position before becoming stationary for the 
duration of the 4 min. trial period. Sometimes, seizures began 
before the entire 4 min. elapsed. The rats were promptly removed 
from the tank at the first signs of seizure, and placed in the 
observation cage. Rats that did not experience seizures in the water 
would lay motionless on their belly until seizures began. The 
latency period to seizure was 2 to 4 min. for rats experiencing their 
first to sixth seizures. From the seventh seizure onwards, latency 
was prolonged to between 4 to 6 min. The first seizures were 
characterized by facial clonus, head nodding, or less commonly, 
forelimb clonus (seizure grades 1-3). In some subjects, forelimb 
clonus was lateralized to one side of the body before spreading to 
include the contralateral side. It was rare for rats to undergo signs 
of severe limbic seizures, grade 4 and 5, with the initial seizure 
induction. Rats whose first seizures were tonic-clonic usually died 
during the episode. Subsequent seizures tended to increase in both 
duration and severity. However, it was not unusual for a rat to have 
a lower grade seizure than the one induced previously. As seizures 
intensified in grade (4-5) to include body contractions, most rats 
fell onto their sides with tonic extension of all limbs. The frequency 
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of body contractions increased before gradually resolving. The rat 
continued to lie on its side with rapid respiration. Regaining of 
consciousness was marked by the animal righting itself and engaging 
in facial grooming with the forelimbs. 
Analysis of data from seizure induction trials using linear 
regression indicates a high correlation between seizure length and 
seizure severity, ranked from 0 to 5, no seizures to severe tonic- 
clonic seizures, respectively (Figure 2 and Appendix II). This 
analysis revealed a general trend in the data: per-incremental 
increase in the seizure grade, 27 seconds is added to the length of 
the seizure. This value can be accepted with 95% certainty as the t- 
statistic value is greater than 2 (Appendix III); however, seizure 
duration varies with each trial and is not a constant for each seizure 
grade. 
Linear regression analysis of the data for all rats that 
experienced hyperthermic seizures found a correlation between the 
number of seizures induced and the seizure duration (Figure 3 and 
Appendix III). Statistical analysis revealed a general trend in the 
data for this population: per-incremental increase in the number of 
seizures, an average of 22.8 seconds is added to the duration of the 
seizure. That is, seizures tended to increase in duration as the 
number of seizures increased. This can be accepted with greater 
than 95% confidence as the t-statistic value is 8.8 (Appendix 
IV). 
Statistical analysis did not find a significant correlation 
between the number of seizures and the seizure grade. Thus, 
seizure duration tended to increase as the number of seizures 

increased, but the subsequent seizures were not necessarily of 
higher grade. This conclusion is reflected in the recorded data. 
Expression Pattern of BDNF mRNA 
Among the normothermic control animals, the pattern and 
intensity of BDNF mRNA expression, as determined by densitometry, 
did not vary significantly with the number of exposures to 37 
water. BDNF mRNA was highly localized to the pyramidal cell layer 
of hippocampal areas CA1 to CA3 and to the granule cell layer of the 
DG although it was detected in lesser amounts in the hilus, 
molecular cell layer, and stratum oriens and radiatum of CA1 and 
CA3 (Figure 4). The mean values for each of the regions examined 
are reported in Table 1. In the controls, the greatest amount of 
BDNF mRNA was detected in the granule cell layer of the DG, with a 
mean value 0.05415 +/_ 0.01 nCi/g. 
In all seizure groups, autoradiograms showed BDNF mRNA 
expression was most highly localized to the pyramidal cell layer of 
hippocampal areas CA1 to CA3 and the granule cell layer of the DG. 
This localization can be seen in Figure 4, in which digitized images 
of the autoradiogram are converted to a color scale that has been 
calibrated to the densitometry values of coexposed 14C standards. 
Figure 4 shows the areas where BDNF mRNA expression increased 
with the number of seizures experienced. The highest level of BDNF 
mRNA expression was observed in region #7, the granule cell layer 
of the DG. The granule cell layer demonstrated a greater than four¬ 
fold increase in BDNF mRNA in the 9 seizure group (mean value 
=0.22967 nCi/g) compared to the control (mean value =0.05415 
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nCi/g). All of the remaining regions—CA1 and CAS, including 
stratum oriens and stratum radiatum, the molecular layer of the DG 
and hilus—show only a 1.5 to 1.7-fold increase in expression after 9 
seizures compared to the control. In particular, pyramidal cell 
layers of CA1 and CAS show the least BDNF mRNA increase, only 1.5- 
fold (Table 1). 
In looking at the set of data specific to each rat, regardless of 
the number of seizures induced, the greatest amount of BDNF mRNA 
expression, in descending order, was observed in region 7 (granule 
cell layer of the DG), then region 5 (CA3 pyramidal cell layer), 
region 2 (CA1 pyramidal cell layer), region 6 (hilus), region 8 
(molecular layer), and region 4 (CA3 stratum radiatum). Stratum 
oriens and radiatum of CA1 had the smallest BDNF mean values of 
all the regions. Although the actual densitometry values varied 
between different animals, this pattern of differential BDNF mRNA 
expression (DG granular cell layer > CA3 pyramidal cell layer > CA1 
pyramidal cell layer<hilus<molecular layer, etc.) was repeated in all 
of the subjects including the controls. 
Statistical Analysis of Regional Differences in the 
Hippocampus 
The Kruskal-Wallis one-way analysis for variance (K-W) 
demonstrated that there is a true difference in the densitometry 
values measured in the granule cell layer of the dentate gyrus (DG) 
among the control and seizure groups, and this can be accepted 
with greater than 98% certainty as the p value is less than .02. 
According to K-W, the difference in values measured in region 1 
(stratum oriens of CA1) approached significance with a p value 

between 0.10 and 0.05. Similarly, the differences in measured 
values for region 8, the molecular layer of the DG, approached 
significance with a p value slightly greater than 0.10 but less than 
0.20. The remaining regions did not demonstrate a statistically 
significant difference between control and seizure groups. 
Appendix I shows the K-W results for all regions examined. 
Inter-group comparisons of BDNF mRNA expression levels by 
the Mann-Whitney U test (M-W) are shown in Table 2. In region 7 
(granular cell layer of the DG), the M-W test indicated a greater 
expression of BDNF mRNA in the 3 seizure group compared to the 
control group (the p value equals .028). Expression was greater in 
the 6 seizure group compared to the controls (the p value equals 
.028). There is greater expression in the 9 seizure group compared 
to the 3 seizure group (the p value equals .05) and to the control 
group (the p value equals .05). M-W analysis of the following 
groups did not yield a statistically significant difference in region 7: 
1 seizure group versus control; 6 seizure group versus 3 seizure 
group; and 9 seizure group versus 6 seizure group. BDNF mRNA 
values obtained from the 3, 6, and 9 seizure groups were all greater 
than any values recorded in the 1 seizure group. However, there 
was not a sufficient number of subjects in the 1 seizure group (n=2) 
to produce a statistically significant difference using the M-W test 
(an n=3 was required for the p value to equal .05 and be statistically 
significant). 
The M-W test was also used to compare measurements 
obtained in region 1 (stratum oriens of CA1) and region 8 
(molecular layer of the DG). In both of these regions, the 
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expression of BDNF iriRNA was found to be greater in the 9 seizure 
group than the control group. This can be accepted with greater 
than 95% certainty because the p value is .028 for both regions. 

Discussion 
I. BDNF mRNA Expression in the Rat 
In the normothermic control rats, BDNF mRNA is most highly 
localized to the granule cell layer of the DG and pyramidal cell layer 
of CA1 to CA3. This is in agreement with prior published studies of 
BDNF mRNA expression in the normal adult rat (90, 91). Our study 
shows that, in the hippocampus, the granular cell layer of the DG 
has the highest density of hybridization to BDNF oligoprobes 
followed by the pyramidal cell layers. This contrasts with earlier 
studies by Ernfors et al. in which CA2 and CAS demonstrated greater 
expression than the DG (90). The CA3 pyramidal cell layer is more 
densely labeled than CA1, and reports by Isackson et al. corroborate 
our finding (91). BDNF mRNA was also detected in lesser quantities 
in the hilus, the molecular layer of the DG, and stratum oriens of 
CA1 and stratum radiatum of CA1 and CA3. 
II. BDNF mRNA Expression in Hyperthermic Seizures, 
Seizure Length, and Neuropathology 
Previous investigations using the warm-water-immersion rat 
model of hyperthermic seizures have shown that short-duration 
seizures do not cause detectable neurodegeneration. In contrast, a 
seizure of prolonged duration, similar to status epilepticus, 
consistently produces a pattern of neurodegeneration with 
remarkable similarities to neuropathology observed in human TLE. 
In the hippocampus, hyperthermic seizures of short-duration 
result in upregulation BDNF mRNA from control levels. The earliest 
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increase was detected after 3 seizures in the granular cell layer of 
the dentate gyrus, exhibiting a two-fold increase compared to 
controls. By 9 seizures, statistically significant increases in BDNF 
mRNA could be detected in stratum oriens of CA1, the hilus and 
granular cell layer of the DG compared to the control group. Peak 
elevation of BDNF mRNA was observed after 9 seizures in all 
hippocampal regions measured. This data demonstrates that the 
amount of BDNF mRNA expression is positively correlated with the 
number of seizures experienced. It also suggests that hyperthermic 
seizures can alter and enhance the hippocampal response to 
subsequent seizure activity, corroborating the conclusions made by 
Chen et al. that febrile seizures are not benign phenomena (92). 
Given the known neuroprotective role of BDNF, upregulation 
of BDNF mRNA in the hippocampus during short-duration seizures, 
in which no neuron loss is detected, supports our hypothesis that 
BDNF protects cells from injury during short-duration hyperthermic 
seizures. Furthermore, regional differences in BDNF mRNA 
expression may offer an explanation for regional differences in 
hippocampal neuron survival after prolonged seizures (66). In the 
hyperthermia-induced status epilepticus rat, the dentate granular 
cell layer is relatively resistant to neuronal injury while the greatest 
amount of neurodegeneration is observed in CA1, and slightly less in 
CAS (66). This pattern of neurodegeneration is similar to 
hippocampal neuron loss found in human TLE (29). In our short- 
duration seizure rats, the highest levels of BDNF mRNA are 
expressed in the dentate granular cell layer. In addition, the 
greatest average increase in BDNF mRNA, after recurrent short- 

duration seizures, occurs in the dentate granular cell layer (4.24- 
fold), while all other hippocampal regions exhibited increases of 
1.5- to 1.7-fold from control values. In comparison to the DG and 
CAS, the CA1 pyramidal cell layer exhibits the least BDNF mRNA 
expression. Furthermore, CA1 and CA3 pyramidal cell layers 
demonstrate the smallest BDNF mRNA response (1.5-fold increase 
compared to controls) to seizure activity of all the hippocampal 
regions examined. Collectively, these findings suggest that an 
insufficient BDNF response in vulnerable regions, may leave neurons 
susceptible to excitotoxic injury and death during prolonged seizure 
activity. We were unable to directly test this hypothesis because the 
status epilepticus rat generated in this experiment was used for a 
separate study of neurodegeneration, rendering it unsuitable for in 
situ hybridization. However, a recent study using the kainic acid 
(KA) rat model, in which status epilepticus is induced, correlated 
the induction of BDNF mRNA with cell survival in the hippocampus 
(93). 
The increase in BDNF expression as a function of the number 
of seizures may contribute to the sprouting of granule cell recurrent 
collaterals into the inner molecular layer (IML) observed in this rat 
model. Prior studies describe a positive correlation between the 
number of hyperthermia-induced seizures in the rat and the extent 
of mossy fiber sprouting in the DG (66). It is possible to infer from 
our present data that a positive correlation also exists between the 
level of BDNF mRNA expression and the extent of mossy fiber 
sprouting in the DG. In vitro studies have demonstrated that 
exogenous BDNF can increase axonal branching of dentate granule 
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cells (82). It is plausible that the high levels of BDNF expression 
induced in the DG, compared to other hippocampal regions, is 
responsible for the unique sprouting of dentate granule cell 
"recurrent mossy fiber" axons. 
One limitation of the present study is that we only examined 
BDNF mRNA levels one hour after seizure activity. Other studies 
employing different methods of seizure induction in the rat—KA 
injection, kindling, hilar lesioning (FIL)--report that the magnitude 
and expression pattern of this mRNA changes depending on the 
amount of time elapsed after the seizure. Peak levels of BDNF mRNA 
are reported in the DG soon after seizure activity; whereas, peak 
levels in CA1 and CA3 occur hours later (94). Nonetheless, all of 
these studies agree with our observation that the DG is the first 
region to show upregulation of BDNF mRNA after seizure activity 
(91, 94, 95). Similarly, in other rat models, the maximum increase 
in seizure-induced BDNF mRNA expression occurs in the DG. This 
increase is two- to six-times the peak response in CA1 or CA3 (91, 
94, 95). 
Statistical analysis of our data reveals a positive correlation 
between the number of hyperthermic seizures induced and the 
seizure duration. Linear regression demonstrates that 22.8 seconds 
is added to the seizure duration per increase in the number of 
seizures (p<0.05). It is possible that, as the number of recurrent 
seizures is increased, the progressively augmented BDNF response 
enhances neuronal excitability which lengthens the seizure duration. 
In fact, BDNF has been shown, in rat models, to enhance excitatory 
synaptic transmission in vivo and in vitro (83-86). In vitro studies 

show that BDNF can enhance excitatory synaptic transmission in the 
DG of human TLE patients (89). 
The results of our study suggest a multi-functional role for 
BDNF upregulation during hyperthermic seizures. It is possible that 
BDNF induction, in high levels and immediately following seizure 
activity, protects neurons from excitotoxic injury and regulates 
mossy fiber sprouting. In neurons expressing BDNF in lower 
amounts and later in time after seizure activity, such as pyramidal 
cells of CA1 and CA3, BDNF functions primarily to enhance neuronal 
excitability. These different functions of BDNF may be accomplished 
if different signaling cascades are coupled to the TrkB receptor. 
Which function is activated may depend either on timing or the 
extent of BDNF induction or on different signaling cascades which 
are unique to specific cell populations. Although elucidation of the 
precise mechanisms which mediate the actions of BDNF in 
hyperthermic seizures is beyond the scope of the present study, our 
data does suggest a multi-functional and more complex role for 
BDNF in hyperthermic seizures than previously proposed. 
III. Relevance for Human TLE and Febrile Convulsions 
The precise role of FCs in the etiology of human TLE remains 
to be determined. Whether or not FCs contribute to the formation 
of the patterns of hippocampal neuron loss sometimes associated 
with human TLE—MTS and hippocampal sclerosis—is still a topic of 
debate among epilepsy researchers. The issue is a long-standing 
and controversial one, and there is data in the literature that 
argues for and against a correlation between a history of FCs and 

the subsequent development of TLE. If FCs contribute to the 
development of TLE in patients, then early recognition and 
treatment of FCs is crucial for preventing the neurological 
sequelae. Our findings in the rat model of hyperthermic seizures 
may offer valuable insight into the effects of humans FCs and its 
role in the pathogenesis of TEE. 
Remarkable similarities exist between the pattern of BDNF 
mRNA expression in the hippocampus of the rat model of 
hyperthermic seizures and human TLE. Human, non-seizure 
autopsy cases demonstrate that, in the hippocampus, BDNF mRNA 
is mainly localized to the DG granule cell layer and stratum 
pyramidale of CA3. Low levels of this mRNA were detected in the 
hilus and, sporadically, in CA1. These regional differences in BDNF 
mRNA expression are also maintained in the hippocampus of the 
adult rat. 
Furthermore, hyperthermic seizures in the rat induce 
increases in BDNF mRNA in the hippocampus. In tissue resected 
from human TLE patients, there is an 89% increase in BDNF mRNA 
in the DG granule cell layer compared to autopsy controls. Lesser 
increases were seen in the hippocampal fields. However, in situ 
hybridization showed more intense BDNF mRNA labeling in the CAS 
pyramidal cells in TLE compared to autopsy controls. BDNF mRNA 
could not be detected in the CA1 region of TLE patients due to 
extensive hippocampal sclerosis (88). These differences in the 
regional upregulation of BDNF mRNA expression in human TLE are 
also observed in the hippocampus of the hyperthermic seizure rat. 
I 
In addition, our previous studies have shown that 
hyperthermic seizures, which are prolonged in duration, produce a 
pattern of hippocampal neuron loss that bears marked 
resemblance to MTS pathology found in TLE: 1) The granule cells 
of the DG are resistant to injury, 2) CAS pyramidal cell layer 
demonstrates neuron loss, 3) the greatest neuron losses are 
detected in the CA1 pyramidal cell layer (66). By comparison, 
hyperthermic seizures of short-duration do not produce detectable 
neuron loss in the rat. These findings corroborate published 
human data which report that the severity of hippocampal neuron 
loss in TLE is strongly associated with prolonged FCs (51, 55, 56). 
Thus, in both the hyperthermic seizure rat and human TLE 
patients, the degree of BDNF mRNA expression in the hippocampus 
appears to associated with the survival of hippocampal neurons. 
Based on these similarities, it is possible to infer from the rat 
model of hyperthermic seizures that, in humans, FCs induce an 
upregulation of BDNF mRNA expression in the hippocampus. The 
increase in BDNF mRNA confers neuroprotective properties against 
seizure-induced neuronal injury and death. However, during 
prolonged FCs, there is an inadequate BDNF mRNA response in 
certain regions in the hippocampus, making these neuron 
populations more susceptible to excitotoxic injury. In this way, 
prolonged FCs can produce the MTS that leads to the development 
of human TLE. In addition to neuroprotection, the increase in BDNF 
mRNA in human TLE may increase excitability of some hippocampal 
neurons, further contributing to epileptogenicity. 
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Although more research is required to confirm this 
hypothesis in human TLE patients, our study using the rat model 
suggests one possible mechanism through which FCs could act to 
produce MTS and TLE. 
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